Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile
- 30 March 2017
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 70 (10) , 838-846
Abstract
Aim: Nowadays, extracellular vesicles are of great interest in prostate cancer (PCa) research. Asparagine (N)-linked glycosylation could play a significant role in the pathological mechanism of these vesicles. We investigated if prostatic protein N-glycosylation profiles were related to urinary vesicle-associated prostate-specific antigen (PSA) extractability and if this parameter showed diagnostic potential for PCa. Methods: Urinary extracellular vesicles were visualised using transmission electron microscopy. Urinary extracellular vesicles extraction by means of n-butanol allowed determination of urinary vesicle-associated PSA extractability. Diagnostic value was assessed between benign prostate hyperplasia (BPH; n=122) and patients with PCa (n=85). Additionally, correlation with urine N-glycosylation was assessed. Results: Urinary extracellular vesicles with a diameter of approximately 100 nm were more abundantly present in urine of patients with PCa versus patients with BPH resulting in a higher vesicle-associated PSA extraction ratio (p<0.001). Next, vesicle-associated PSA extraction ratio was correlated to biantennary core-fucosylation (p=0.003). Finally, vesicle-associated PSA extraction ratio proved beneficial in PCa diagnosis, next to serum PSA and the urinary glycosylation marker (p=0.021). Conclusions: The urinary vesicle-associated PSA extraction ratio is increased in PCa which is a direct result of the abundant presence of extracellular vesicles in urine of patients with PCa. The urinary vesicle-associated PSA extraction ratio was associated with changes in N-glycoforms and showed diagnostic potential. Further research is warranted to unravel the pathological link between N-glycosylation and extracellular vesicles in cancer, as well as to assess the prognostic value of this biomarker.Keywords
This publication has 42 references indexed in Scilit:
- Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate CancerPLOS ONE, 2013
- Increased bisecting N‐acetylglucosamine and decreased branched chain glycans of N‐linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionProteomics – Clinical Applications, 2013
- In‐depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urineProteomics, 2013
- Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate CancerPLOS ONE, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- An extremely simple method for extraction of lysophospholipids and phospholipids from blood samplesJournal of Lipid Research, 2010
- Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic DiseaseCancer Research, 2009
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerBritish Journal of Cancer, 2009
- Exosomes as a tumor immune escape mechanism: possible therapeutic implicationsJournal of Translational Medicine, 2008
- Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical PracticeClinical Chemistry, 2005